Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on JOHNSON & JOHNSON
09/03 JOHNSON & JOHNSON : to Participate in the 2015 Morgan Stanley Healthcare Confere..
09/02 JOHNSON & JOHNSON : TSRI & Janssen study makes major advance toward more effecti..
09/02 JOHNSON & JOHNSON : Reports from Johnson & Johnson Highlight Recent Findings in ..
09/02 JOHNSON & JOHNSON : U.S. FDA Approves Update Of SIMPONI ARIA® (Golimumab For Inf..
09/01 PFIZER : Sc dismisses government plea in pfizer cough syrup case
09/01 JOHNSON & JOHNSON : J&J MARKS Rs650 CRORE MORE FOR TELANGANA
09/01 JOHNSON & JOHNSON : New Global Real-World Data from Atrial Fibrillation Studies ..
09/01 Insulin infusion device maker CeQur raises $100 million
09/01 JOHNSON & JOHNSON : to Take Part in the 2015 Wells Fargo 10th Annual Healthcare ..
08/31 JOHNSON & JOHNSON : to Participate in the 2015 Wells Fargo 10th Annual Healthcar..
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials